Contract Pharma

Breaking News | Collaborations & Alliances | Drug Development | Industry News | Preclinical Outsourcing

Nanoform, Boehringer Ingelheim Sign Master Services Agreement

Will address bioavailability and solubility challenges in the pre-clinical early development stages.

08.03.21

Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Solid Dosage/Creams/Ointments

DisperSol, Catalent Enter Manufacturing Collaboration

To establish KinetiSol technology manufacturing hub for DisperSol’s pipeline.

08.03.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

CellCAN and CCRM Partner to Launch CATTI

New Institute will tackle gaps in training Canada’s GMP workforce.

07.29.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Akston Biosciences, Seppic Ink Commercial Supply Agreement

Deal is for an adjuvant to formulate shelf-stable COVID-19 vaccine at global scale.

07.29.21

Abzena, BioXpress Therapeutics Enter Biosimilar Tie-up

Partnership to support the development and manufacture of biosimilars for global customers.

07.29.21

Breaking News | Collaborations & Alliances | Industry News

CatSci and Argonaute RNA Enter CMC Development Collaboration

Aim to expedite oligonucleotide manufacturing for gene-silencing therapeutics.

07.27.21

Breaking News | Collaborations & Alliances | Facilities | Industry News

Grifols Expands Activity in Africa

Will set up an intravenous solutions manufacturing plant in Nigeria.

07.27.21

Bio News | Breaking News | Collaborations & Alliances | Industry News

AavantiBio, Aldevron Form Gene Therapy Partnership

Aldevron will supply plasmids to AavantiBio’s planned vector core and CDMO partners.

07.27.21

Alloy Therapeutics, Echo Investment Capital Create Wheeler Bio

New company set up to accelerate the development of new antibody therapeutics.

07.27.21

Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News

Marvel Biotechnology Begins cGMP Manufacturing of Lead Candidate

Enters manufacturing agreement with Ausun Pharma for lead asset MB-204.

07.22.21

Bio News | Breaking News | Collaborations & Alliances | Industry News

Minaris and bluebird bio Enter Manufacturing Pact

The CDMO will be the commercial manufacturer in Europe for Skysona, bluebird bio’s gene therapy for CALD.

07.22.21

Breaking News | Collaborations & Alliances | Industry News

Nanopharm, Leyden Labs to Develop Nasal Spray Drugs

Intranasal spray product candidates will target known and new respiratory viruses.

07.22.21

Aptamer and WuXi AppTec Form Research Partnership

Collaborate to identify new Optimer-enabled therapeutics.

07.22.21

Breaking News | Collaborations & Alliances | Industry News | Parenterals

ExeVir, Mithra CDMO Enter Manufacturing Collaboration

Manufacturing of ExeVir's candidate product for Covid-19 Treatments will take place at Mithra CDMO's new injectable facility.

07.20.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Intravacc's Inactivated Polio Vaccine Out-licensed to Sinovac

Sinovac's Eupolio vaccine (sIPV) receives market authorization from the NMPA in China.

07.20.21

Samsung Biologics, Kineta Enter Development and Manufacturing Agreement

Samsung's San Francisco R&D center and South Korea headquarters to offer end-to-end CDMO service for anti-VISTA antibody immunotherapy.

07.20.21

Aseptic Processing | Breaking News | Collaborations & Alliances | Industry News | Parenterals

Steriline Supplies Shilpa Medicare with Pilot Line for Injectable Oncology Drugs

Shilpa requested the new pilot line with very small footprint to process vials, pre-filled syringes and cartridges.

07.20.21

Breaking News | Collaborations & Alliances | Industry News | Information Technology | Supply Chain

Skyepharma Bolsters Data Integrity Capabilities

CDMO partners with Veratrak to guarantee data integrity for batch manufacturing records.

07.20.21

Curtana and Catalent Enter Brain Cancer Drug Partnership

Sign development and manufacturing agreement for brain cancer drug CT-179.

07.16.21

Batavia Manufactures IAVI’s Lassa Fever Vax Candidate

Uses innovative 'scale-X' bioreactor to support Phase I clinical trials.

07.14.21

Breaking News | Collaborations & Alliances

Bicycle Therapeutics, Ionic Pharma Enter License & Collaboration Agreement

Will work together to develop targeted oligonucleotide therapeutics leveraging tissue-targeting TfR1 Bicycle technology.

07.13.21

I-Mab Expands Next-Gen Novel Oncology Portfolio

Expands pipeline of antibody assets leveraging cutting-edge mRNA and AI technology platforms.

07.09.21

Batavia to Develop Clinical Process for RocketVax’s COVID-19 Vaccine

After successful completion, Batavia will continue to scale-up and optimize the process for commercial scale.

07.08.21

Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology

SRI, Sanofi Enter Drug Discovery Collaboration

Will leverage SynFini, SRI’s artificial intelligence and automation platform to accelerate development of small-molecule drug targets.

07.07.21

Collaborations & Alliances | Drug Development

Y-Biologics, Pierre Fabre Enter Immuno-oncology Alliance

Aims to develop and commercialize a family of human antibodies to inhibit the growth of tumor cells.

07.07.21

BioMed X Expands Collaboration with Merck

Launches a new joint research program in oncology.

07.06.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Cytotoxics and High Potency Manufacturing | Industry News

Novasep, Exelixis Ink ADC Manufacturing Agreement

Covers the cGMP clinical manufacturing of a next-generation ADC drug candidate.

07.06.21

Bio News | Breaking News | Collaborations & Alliances | Industry News

Aragen Expands Discovery Research Agreement with Boehringer Ingelheim

Aims to accelerate the discovery pipeline of Boehringer Ingelheim.

07.01.21

Breaking News | Collaborations & Alliances | Industry News

Innovent Biologics Signs License Agreement with Synaffix

Synaffix will provide proprietary ADC technologies to enable Innovent to rapidly progress one of its antibodies as a best-in-class ADC candidate.

07.01.21

Bio News | Breaking News | Collaborations & Alliances | Industry News

Waters Corp Expands Collaboration with BTI

Intends to accelerate bioprocessing and bioinformatics research in Singapore.

07.01.21

Analytical Services | Breaking News | cGMP Manufacture | Collaborations & Alliances | Formulation Development

Selexis, KBI Biopharma, Immatics Partner to Advance TCR Program

Will leverage integrated services from Selexis and KBI as part of Immatics’ development of TCR Bispecifics, designed to detect, target and attack tumor cells.

06.30.21

Breaking News | Clinical Trials | Collaborations & Alliances | Industry News | Information Technology

CMIC and Lokavant Partner to Deploy Clinical Trial Intelligence Platform

Enter first phase of multi-year partnership to deploy predictive analytics platform for monitoring and management of clinical trials in Asia-Pacific.

06.29.21

Breaking News | Collaborations & Alliances | Facilities | Industry News

WuXi STA Chooses Middletown Delaware for New Pharma Manufacturing Campus

The CDMO is bringing about 500 jobs to Middletown, with site expected to open in 2024.

06.29.21

Cobra Biologics, CombiGene Ready to Start GMP Production of Epilepsy Drug Candidate

Complete production and quality assurance of the plasmids to be used in the GMP production of CG01.

06.25.21

Breaking News | Collaborations & Alliances

CellPoint and Lonza Enter CAR-T Cell Collaboration

Will work together to deliver CAR-T Cell therapies to patients at point-of-care.

06.24.21

Breaking News | Collaborations & Alliances

Cellenkos Chooses Cryoport to Support Covid-19 Therapy Shipments to Patients

Cryoport will provide tracking and proactive management for the therapies.

06.22.21

Breaking News | Collaborations & Alliances

Iksuda, LegoChem Expand ADC Alliance

Grants Iksuda access to LegoChem's next generation ADC platform for up to six targets.

06.22.21

Collaborations & Alliances | Drug Development

ProBioGen, LAVA to Develop Cell Lines for Bispecific Candidate

ProBioGen will conduct cell line development of a novel gamma-delta bsTCE using its CHO.RiGHT expression platform.

06.22.21

Breaking News | Collaborations & Alliances | Drug Development

Jacobio Earns $20M AbbVie Milestone

Initiates Phase 1/2a trial of SHP2 inhibitor JAB-3312 in combination with PD-1 antibody Pembrolizumab and MEK inhibitor Binimetinib.

06.18.21

Breaking News | Collaborations & Alliances | Industry News

KBI Biopharma, AM-Pharma Enter Manufacturing Agreement

Partnership supports future commercial manufacturing for AM-Pharma’s potential kidney disease treatment.

06.17.21

Breaking News | Collaborations & Alliances | Drug Development | Formulation Development

Lumen Bioscience, Novo Nordisk Enter Metabolic Research Pact

To explore Lumen's drug development and manufacturing platform to deliver oral biologics for cardiometabolic disease.

06.16.21

Ocugen, Jubilant Enter COVID-19 Vaccine Partnership

Jubilant HollisterStier to manufacture COVAXIN for the U.S. and Canadian markets.

06.15.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

VERAXA and Quadira Enter ADC Development Partnership

To develop a suite of novel ADCs for the treatment of oncological conditions.

06.15.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development

iTeos Therapeutics, GSK Enter Monoclonal Antibody Alliance

GSK now has a leading portfolio of antibodies targeting the CD226 axis, a key target for next-gen immuno-oncology therapies

06.14.21

Enteris BioPharma Receives $10M Milestone from Cara Therapeutics

Third milestone payment related to the development of Oral KORSUVA.

06.11.21

Revolo and Northway Biotech Enter Manufacturing Partnership

To manufacture novel binding immunoglobulin protein, ‘1805, to support phase 2 trials in rheumatoid arthritis and uveitis.

06.11.21

WuXi XDC and LegoChem Ink ADC Agreement

Sign MOU for the development and manufacturing of antibody-drug conjugates.

06.11.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

AGC Biologics Inks Supply Deal for COVID-19 Vaccine

CDMO’s Heidelberg facility to supply plasmid DNA for Pfizer/BioNTech COVID-19 vaccine.

Tim Wright, Editor, Contract Pharma 06.07.21

Portonbio Enters CAR-T Partnership with KAEDI

CDMO will provide KAEDI with CMC services for multiple projects.

Tim Wright, Editor, Contract Pharma 06.07.21

Exelead Helps Manufacture Pfizer-BioNTech COVID-19 Vaccine

Pharmaceutical development and manufacturing company delivers first vaccine batch to Pfizer.

Tim Wright, Editor, Contract Pharma 06.07.21

FOLLOW:

Search Results for 'collaboration'

July/August 2021

follow us